Halopropane

Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.^[1] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.^[2][3][4]

Halopropane

Clinical data
Trade names	Tebron
ATC code	None
Identifiers
IUPAC name 3-Bromo-1,1,2,2-tetrafluoropropane
CAS Number	679-84-5
PubChem CID	69623
ChemSpider	62826
UNII	3DC4A5894W
CompTox Dashboard (EPA)	DTXSID40862366
Chemical and physical data
Formula	C3H3BrF4
Molar mass	194.955 g·mol−1
3D model (JSmol)	Interactive image
SMILES C(C(C(F)F)(F)F)Br
InChI InChI=1S/C3H3BrF4/c4-1-3(7,8)2(5)6/h2H,1H2 Key:YVWGMAFXEJHFRO-UHFFFAOYSA-N

See also

• Aliflurane
• Roflurane
• Synthane